Wells Fargo
ARIA

Wells Fargo’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Wells Fargo’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-178,632
Closed -$2.22M – 6736
2016
Q4 		$2.22M Buy
178,632
+62,205
+53% +$749K ﹤0.01% 3079
2016
Q3 		$1.59M Buy
116,427
+8,205
+8% +$82.4K ﹤0.01% 3141
2016
Q2 		$800K Sell
108,222
-6,148
-5% -$46.1K ﹤0.01% 3631
2016
Q1 		$731K Buy
114,370
+21,688
+23% +$122K ﹤0.01% 3609
2015
Q4 		$579K Buy
92,682
+17,453
+23% +$115K ﹤0.01% 3840
2015
Q3 		$439K Sell
75,229
-172,327
-70% -$1.33M ﹤0.01% 4026
2015
Q2 		$2.05M Sell
247,556
-27,264
-10% -$241K ﹤0.01% 3087
2015
Q1 		$2.27M Sell
274,820
-2,932
-1% -$21.7K ﹤0.01% 2951
2014
Q4 		$1.91M Buy
277,752
+35,801
+15% +$224K ﹤0.01% 3039
2014
Q3 		$1.31M Buy
241,951
+140,114
+138% +$818K ﹤0.01% 3287
2014
Q2 		$649K Buy
101,837
+14,144
+16% +$97.3K ﹤0.01% 3787
2014
Q1 		$707K Buy
87,693
+29,380
+50% +$229K ﹤0.01% 3703
2013
Q4 		$398K Sell
58,313
-419,793
-88% -$2.27M ﹤0.01% 3921
2013
Q3 		$8.8M Sell
478,106
-24,631
-5% -$478K ﹤0.01% 1743
2013
Q2 		$8.79M Buy
+502,737
New +$8.91M ﹤0.01% 1681

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Wells Fargo's ARIA Position: Q1 2017 in Review

Wells Fargo sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 178,632 shares — an estimated $2.22M sold.

Wells Fargo first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $8.8M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Wells Fargo reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Wells Fargo sold 178,632 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.22M.
  • Wells Fargo first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Wells Fargo's Ariad Pharmaceuticals Inc position peaked at $8.8M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Wells Fargo's 13F filing for Q1 2017, filed 28 Apr 2017.